Comparison of the inhibitory effects of two types (90 kDa and 190 kDa) of hyaluronic acid on the expression of fibrinolytic factors in human synovial fibroblasts

References

• Matsuo 0, Ftijken DC, Collen D. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature 1981;291:590–1.
   Google Scholar
• Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980;43:77–89.
   PubMed Web of Science ®Google Scholar
• Fukao H, Ueshima S, Takaishi T, Okada K, Matsuo 0. Enhance-ment of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells. Biochim Biophys Acta 1997;1356:111–20.
   Google Scholar
• Hagiya Y, Fukao H, Ueshima S, Okada K, Inufusa H, Kamiishi H, et al. Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line. Clin Chim Acta 1996;253: 37–50.
   PubMed Web of Science ®Google Scholar
• Robinson RM, Taylor RE, Hansen B. Evidence for an extracellu-lar plasmin-dependent proteolytic system in mineralizing matrices. Calcif Tissue Int 1984;36:31–8.
   Google Scholar
• Dam) K, Anderson PA, Grondahl-Hansen J, Kristensen P, Neilsen S, Skriver L. Plasminogen activators, tissue degradation and can-cer. Adv Cancer Res 1985;44:139–244.
   PubMedGoogle Scholar
• Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381–7.
   PubMed Web of Science ®Google Scholar
• Barnathan ES, Kuo A, Kariko K, Rosenfeld L, Murray SC, Behrendt N, et al. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and m-RNA. Blood 1990;76:1795–806.
   PubMedGoogle Scholar
• Dan0 K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen acti-vation and cancer invasion. Fibrinolysis 1994;8 Suppl 1:189–203.
   Google Scholar
• Gardsvoll H, Dan0 K, Ploug M. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis. J Biol Chem 1999;274:37995–8003.
   Google Scholar
• Ellis V. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymographic nature of pro-urokinase. J Biol Chem 1996;271: 14779–84.
   Google Scholar
• Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S. Significance of serine protease and matrix metalloproteinase sys-tems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol 1996;23:885–9.
   Google Scholar
• Nonaka T, Matsumoto H, Shimada W, Miyagi I, Okada K, Fukao H, et al. Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line. Biochim Biophys Acta 1995;1266:50–6.
   PubMedGoogle Scholar
• Nonaka T, Matsumoto H, Shimada W, Okada K, Fukao H, Ueshima S, et al. Effect of bone resorbing factors on u-PA and its specific receptor in the osteosarcoma cell line. Clin Chim Acta 1993;223:129–42.
   PubMedGoogle Scholar
• Leizer T, Clarris BJ, Ash PE, van Damme J, Saklatvala J, Hamilton JA. Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum 1987;30: 562–6.
   Google Scholar
• Clarris BJ, Leizer T, Fraser JR, Hamilton JA. Diverse morphologi- 29. cal responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1. Ftheumatol Int 1987;7: 35–41.30.
   Google Scholar
• Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local 31. and systemic manifestations of arthritis. J Clin Invest 1989;83: 585–92.
   Google Scholar
• Butler DM, Piccoli DS, Hart PH, Hamilton JA. Stimulation of 32. human synovial fibroblast DNA synthesis by recombinant human cytokines. J Ftheumatol 1988;15:1463–70.
   Google Scholar
• Saxne T, Lecander I, Geborek P. Plasminogen activators and plas- 33. minogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Ftheumatol 1993;20: 91–6.34.
   Google Scholar
• Pianon M, Punzi L, Stefani MP, Bertazzolo N, Michelotto M, Finco B, et al. Interleukin-1 beta, plasminogen activator and inhibitor of plasminogen activator in synovial fluid of rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Agents Actions 1994;41:88-9. 35.
   Google Scholar
• Busso N, Peclat V, So A, Sappino AP. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 1997;56:550-7.36.
   Google Scholar
• Szekanecz Z, Haines GK, Koch AE. Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues. J Clin Pathol 1997;50: 314–9.
   Google Scholar
• Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. 37. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Fthuem 1993;36: 247–53.38.
   Google Scholar
• Swann DA, Radin EL, Nazimiec M, Weisser PA, Curran N, Lewinnek G. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 1974;33:318–26.
   PubMed Web of Science ®Google Scholar
• Tomota K. Effects of high molecular weight hyaluronon on the 39. functions of pig phagocytes. Microbiol Immunol 1994;38:73–80.
   PubMedGoogle Scholar
• Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheuma- 40. toid arthritis. J Ftheumatol 2000;27:997–1004.
   Google Scholar
• Nonaka T, Kikuchi H, Shimada W, Ikeda T, Hamanishi C, Tanaka S, et al. Effect of sodium hyaluronic acid on fibrinolytic factors in the synovial fluid (in vivo). Pathophysiology 1999;6:41–4.
   Google Scholar
• Matsuo C, Fukao H, Matsuo 0. Characterization of plasminogen 41. activator produced by an established cell line from human ovary. J Cell Physiol 1988;134: 253–60.
   Google Scholar
• Nagata Y, Fukuda K, Matsumura H, Motoyoshi H, Yamasaki H, Tanaka S. Secretion of hyaluronic acid from synovial fibroblasts enhanced by histamine: a newly observed metabolic effect of hista-mine. J Lab Clin Med 1992;120:707–12.
   PubMedGoogle Scholar
• Altman RD. Criteria for classification of clinical osteoarthritis. J Ftheumatol 1991;18:10–2.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheuma-toid arthritis. Arthritis Rheum 1988;31: 315–24.
   Google Scholar
• Matsuo 0, Sakai T, Bando H, Okada K, Nakajima S, Takagi 0, et al. Plasminogen activator in bronchoalveolar fluid. Haemostas is 1986;16:43–50.
   Google Scholar
• Stoppelli MP, Tacchetti C, Cubellis MV, Corti A, Hearing VJ, Cassani G, et al. Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 1986;45:675–84.
   PubMed Web of Science ®Google Scholar
• Nonaka T, Okada K, Fukao H, Ueshima S, Kikuchi H, Tanaka S, et al. Regulation of scu-PA secretion and u-PA receptor ex-pression in osteoblast-like cells. Cell Struct Funct 1993;18:355–62.
   PubMedGoogle Scholar
• Yasuda Y, Itoh K, Mizuno N, Konishi H, Tanimura T. Alterations in migrating cranial neural crest cells in embryos of mice fed retinoic acid. Anal Cell Pathol 1989;2:23–40.
   Google Scholar
• Yasui T, Akatsuka M, Ando M. The effect of hyaluronan on interleukin-l-ct-induced prostaglandin E2 production in human osteoarthritic synovial cells. Agents Actions 1992;37: 155–6.
   Google Scholar
• Punzi L, Schiavon F, Todesco S. The influence of intra-articular hyaluronic acid on PGE2 and cAMP in synovial fluid. Clin Exp Ftheumatol 1989;7: 247–50.
   Google Scholar
• Hamilton JA, Wojta J, Gallichio M, Mcgrath K, Filonzi EL. Con-trasting effects of transforming growth factor-n and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J Immunol 1993;151: 5154–61.
   Google Scholar
• Hamilton JA, Cheung D, Filonzi EL, Piccoli DS, Wojta J, Gallichio M, et al. Independent regulation of plasminogen activator inhibi-tor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts. Arthritis Rheum 1992;35:1526–34.
   PubMedGoogle Scholar
• Cerinic MM, Generini S, Partsch G, Pignone A, Dini G, Konttinen YT, et al. Synoviocytes from osteoarthritis and rheumatoid arthri-tis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. Life Sci 1998;63:441–53.
   PubMed Web of Science ®Google Scholar
• Aertgeerts K, Bondt HL, De Ranter CJ. Mechanism contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nature Struct Biol 1995;2:891–7.
   Google Scholar